Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19
Authors
Keywords
Angiotensin converting enzyme 2, Apelin, Severe acute respiratory syndrome coronavirus 2, COVID-19, SGLT2 inhibitor, Inflammation
Journal
INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-05-15
DOI
10.1016/j.ijcard.2021.05.029
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors
- (2020) Thomas A. Zelniker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
- (2020) Mahmoud Gheblawi et al. CIRCULATION RESEARCH
- Multiorgan and Renal Tropism of SARS-CoV-2
- (2020) Victor G. Puelles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system
- (2020) Wei Liu et al. Annals of Translational Medicine
- Apelin-potential therapy for COVID-19?
- (2020) Seyed Soheil Saeedi Saravi et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Myocardial injury and COVID-19: Possible mechanisms
- (2020) Savalan Babapoor-Farrokhran et al. LIFE SCIENCES
- SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
- (2020) Martin R. Cowie et al. Nature Reviews Cardiology
- COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
- (2020) Razie Amraei et al. Cells
- ACE/ACE2 Ratio: A Key Also in 2019 Coronavirus Disease (Covid-19)?
- (2020) Pasquale Pagliaro et al. Frontiers in Medicine
- Heart failure in COVID‐19 patients: prevalence, incidence and prognostic implications
- (2020) Juan R. Rey et al. EUROPEAN JOURNAL OF HEART FAILURE
- Nephrology and COVID-19
- (2020) Wolfgang C. Winkelmayer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 can affect the heart
- (2020) Eric J. Topol SCIENCE
- Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
- (2020) Antonella Fara et al. Open Biology
- Increased plasma ACE2 concentration does not mean increased risk of SARS-CoV-2 infection and increased fatality rate of COVID-19
- (2020) Xueting Li et al. Acta Pharmaceutica Sinica B
- Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19
- (2020) Enrico Brunetta et al. NATURE IMMUNOLOGY
- Apelin Is a Negative Regulator of Angiotensin II–Mediated Adverse Myocardial Remodeling and DysfunctionNovelty and Significance
- (2017) Zhen-Zhou Zhang et al. HYPERTENSION
- Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling
- (2015) Hai-Yan Jin et al. Journal of Translational Medicine
- Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction
- (2010) JiuChang Zhong et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now